BusinessHealthTop Stories

Implantable Drug Delivery Market Valued $ 36.12 Bn by 2025 | A report by Bayer, Boston Scientific, Medtronic, Merck&Co. Inc., Allergan Inc., Bausch and Lomb and others

Implantable Drug Delivery market report gives key measurements available status of the Manufacturers and is a significant wellspring of direction and bearing for organizations and people inspired by the Healthcare Industry. In Implantable Drug Delivery Market report, there is an area for rivalry scene of the global Healthcare Industry.  The report then analyses company profiles and the growth strategies of the major Implantable Drug Delivery Market leaders. A detailed study of product picture and specifications, revenue, cost, price, gross, capacity and production, company profiles, and contact information is carried out in the analysis of Healthcare industry key manufacturer’s section.

Market Analysis:

The Global Implantable Drug Delivery Market is expected to reach USD 36.12 billion by 2025, from USD 19.36 billion in 2017 growing at a CAGR of 8.0% during the forecast period of 2018 to 2025. The upcoming market report contains data for historic year 2016, the base year of calculation is 2017 and the forecast period is 2018 to 2025.

Download Sample PDF Report

Top Players:

  • Bayer
  • Boston Scientific
  • Medtronic
  • Merck&Co. Inc.
  • Allergan Inc.
  • Bausch and Lomb, Inc.
  • Ithetis
  • Nucletron
  • Genetech Inc.
  • Theragenics
  • Psivida
  • Kinamed Inc.
  • K2M Inc.
  • Mako Surgical Corp.
  • Varian Medical System
  • Arrow International
  • Eckert Ziegler
  • Elekta
  • JVS
  • Abbottamong among others

Key Developments in the Market:

  • In March 2016, FDA approved V-Go, a wearable 24 hour subcutaneous insulin delivery device by Medtronic for diabetes management, which have helped diabetes treatment outcome.
  • In April 2013, Bayer Healthcare launched a hormonal intrauterine device (IUD) called Skyla. The product is launched in Europe with the brand name Jaydess, and is used for the prevention of pregnancy for up to three years.


Major Market Drivers and Restraints:

  • Increasing Adaptation Towards Minimally Invasive Surgeries
  • Increasing Prevalence Of Chronic Diseases
  • Rising Emerging Economies
  • Rising Number Of Product Recalls
  • Stringent Government Regulations

Segmentation :

  • biodegradable implantable drug delivery device technology
  • non-biodegradable implantable drug delivery device technology.


  • cardiovascular
  • birth control & contraception
  • ophthalmology
  • oncology and others


  • North America
  • South America
  • Europe
  • Asia-Pacific
  • Middle East
  • Africa

Major countries

  • US., Canada, Germany, France, U.K., Netherlands, Switzerland, Turkey, Russia, China, India, South Korea, Japan, Australia, Singapore, South Africa and, Brazil among others.

Share Analysis:

The global implantable drug delivery market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of implantable drug delivery market for global, Europe, North America, Asia Pacific and South America.

Request Analyst Call for More Insight @


Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *